New approach for treating idiopathic pulmonary fibrosis Researchers have identified a potential novel drug target for idiopathic pulmonary fibrosis, a dangerous chronic lung disease. They elucidated a new mechanism of fibrosis formation that plays an important role in the pathogenesis of the disease.
Breakthrough against hospital superbug, klebsiella pneumoniae Researchers have developed a cutting-edge new medical therapy that could protect hospital patients against a lethal superbug.
Why obesity predisposes to severe respiratory failure A hormone that regulates blood sugar levels may be the key to reducing the risk of acute respiratory distress syndrome in obese patients.
Older asthma patients at increased risk for treatment failure Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled corticosteroids.
Potential treatment for fatal lung diseases Researchers have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal. Pulmonary fibrosis occurs when lung tissue becomes scarred. Pulmonary hypertension involves an increase of blood pressure in the arteries of the lung that can lead to heart failure.